These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 25673511)

  • 1. Long-term angiographic outcomes of sirolimus- and paclitaxel-eluting stent placement in diabetes, long lesions, and small vessels.
    Nakano Y; Ishikawa T; Mutoh M
    Cardiovasc Interv Ther; 2015 Oct; 30(4):327-37. PubMed ID: 25673511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propensity score matched lesion-based comparison of long-term clinical and angiographic outcomes after placement of sirolimus (Cypher Bx Velocity) and paclitaxel (TAXUS Express)-eluting stents for de novo native coronary stenosis.
    Nakano Y; Ishikawa T; Hino S; Mutoh M
    Cardiovasc Interv Ther; 2014 Apr; 29(2):93-101. PubMed ID: 24122399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
    Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
    J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Midterm angiographic outcomes with sirolimus- and everolimus-eluting stents for small vessels in diabetic patients: propensity-score-matched comparisons in three different vessel diameters.
    Suzuki K; Ishikawa T; Mutoh M; Sakamoto H; Kubota T; Ogawa T; Mori C; Hashimoto K; Komukai K; Yoshimura M;
    Cardiovasc Interv Ther; 2018 Jul; 33(3):205-216. PubMed ID: 28349417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propensity-Score Matched Comparison of Midterm Angiographic Outcomes of Sirolimus- Versus Everolimus- and Biolimus-Eluting Stents for De Novo Coronary Stenosis.
    Suzuki K; Ishikawa T; Mutoh M; Sakamoto H; Mori C; Ogawa T; Hashimoto K; Kubota T; Komukai K; Yoshimura M;
    Int Heart J; 2017 May; 58(3):320-327. PubMed ID: 28484124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel versus sirolimus eluting stents in diabetic patients: does stent type and/or stent diameter matter?: long-term clinical outcome of 2,429-patient multicenter registry.
    Tarantini G; Facchin M; Capodanno D; Musumeci G; Saia F; Menozzi A; Meliga E; Mancone M; Lettieri C; Tamburino C
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):80-9. PubMed ID: 22511311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents for the treatment of ostial coronary lesions: comparison of sirolimus-eluting stent with paclitaxel-eluting stent.
    Chen J; Li JJ; Chen JL; Qiao SB; Xu B; Yang YJ; Gao RL; Qin XW; Yuan JQ; Yao M; Wu YJ; Liu HB; Dai J; You SJ
    Coron Artery Dis; 2008 Nov; 19(7):507-11. PubMed ID: 18923247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
    Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
    J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Very long-term clinical and angiographic outcomes after sirolimus- and paclitaxel-eluting stent placement for ST-elevation myocardial infarction: a propensity score-matched comparison.
    Miyamoto T; Ishikawa T; Nakano Y; Mutoh M
    Cardiovasc Interv Ther; 2017 Jan; 32(1):24-35. PubMed ID: 26979599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-year outcomes from the TAXUS express stent versus cypher stent.
    Mayor M; Malik AZ; Minor RJ; Deshpande MC; Strauss WE; Maloney TH; Baim DS; O'Neill W; Kandzari DE
    Am J Cardiol; 2009 Apr; 103(7):930-6. PubMed ID: 19327418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sirolimus-eluting versus paclitaxel-eluting stents in diabetic and non-diabetic patients within sirolimus-eluting stent restenosis: results from the ISAR-DESIRE 2 trial.
    Kufner S; Byrne RA; de Waha A; Schulz S; Joner M; Laugwitz KL; Kastrati A;
    Cardiovasc Revasc Med; 2014 Mar; 15(2):69-75. PubMed ID: 24684757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Kirtane AJ; Patel R; O'Shaughnessy C; Overlie P; McLaurin B; Solomon S; Mauri L; Fitzgerald P; Popma JJ; Kandzari DE; Leon MB
    JACC Cardiovasc Interv; 2009 Oct; 2(10):967-76. PubMed ID: 19850257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus-eluting stents versus Paclitaxel-eluting stents in the treatment of coronary artery disease in patients with diabetes mellitus.
    Kuchulakanti PK; Chu WW; Torguson R; Clavijo L; Wolfram R; Mishra S; Xue Z; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
    Am J Cardiol; 2006 Jul; 98(2):187-92. PubMed ID: 16828590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.
    Cosgrave J; Agostoni P; Ge L; Iakovou I; Chieffo A; Biondi-Zoccai GG; Sangiorgi GM; Montorfano M; Michev I; Airoldi F; Carlino M; Corvaja N; Bonizzoni E; Colombo A
    Am J Cardiol; 2005 Dec; 96(12):1663-8. PubMed ID: 16360354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus-eluting stents compared with paclitaxel-eluting stents for treatment of coronary in-stent restenoses.
    Markovic S; Paliskyte R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2012; 13(6):307-10. PubMed ID: 23164475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effectiveness of sirolimus- and paclitaxel-eluting stents for small coronary artery lesions.
    Park KH; Park SW; Hong MK; Kim YH; Lee BK; Park DW; Choi BR; Kim MJ; Park KM; Lee CW; Cheong SS; Kim JJ; Park SJ
    Catheter Cardiovasc Interv; 2006 Apr; 67(4):589-94. PubMed ID: 16547937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sirolimus-eluting and Paclitaxel-eluting stents on outcome in patients with diabetes mellitus and stenting in more than one coronary artery.
    Stankovic G; Cosgrave J; Chieffo A; Iakovou I; Sangiorgi G; Montorfano M; Airoldi F; Carlino M; Michev I; Finci L; Colombo A
    Am J Cardiol; 2006 Aug; 98(3):362-6. PubMed ID: 16860024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus.
    Zhang F; Dong L; Ge J
    Am J Cardiol; 2010 Jan; 105(1):64-8. PubMed ID: 20102892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.